Nedocromil is a synthetic anti-inflammatory and mast cell stabilizing pharmaceutical compound belonging to the cromone class. It is primarily associated with the management of asthma and allergic airway conditions and has also been used in ophthalmic formulations for allergic eye disorders.
Nedocromil acts locally on inflammatory cells involved in allergic and airway responses. It helps reduce the release of inflammatory mediators from mast cells and other cells involved in airway inflammation.
Nedocromil is an important pharmaceutical compound for respiratory, allergy and ophthalmic drug research, as well as formulation development and analytical applications.
Nedocromil is a well-characterized respiratory and anti-allergic pharmaceutical API relevant to pharmaceutical formulation development, analytical testing and research involving mast-cell stabilization and inflammatory mediator release.
Important API quality attributes include identity, assay, related substances, water content, residual solvents, elemental impurities and other applicable pharmaceutical quality parameters.
CAS Number: 69049-73-6
Molecular Formula: C19H21NO7
Molecular Weight: 375.38 g/mol
Chemical Name: Nedocromil
Drug Class: Mast Cell Stabilizer / Cromone
Therapeutic Class: Anti-inflammatory / Antiallergic
Therapeutic Area: Respiratory Medicine / Allergy / Ophthalmology
Molecule Type: Synthetic Small Molecule
Nedocromil acts primarily as a mast cell stabilizer and anti-inflammatory compound.
Its pharmacological effects include:
Nedocromil does not function as a conventional bronchodilator. Its therapeutic role is primarily related to preventing or reducing inflammatory and allergic responses.
Nedocromil API is relevant to:
Nedocromil has been used as a preventive anti-inflammatory treatment for asthma and other airway inflammatory conditions.
Its activity is associated with suppression of inflammatory mediator release and reduction of airway responsiveness. Because it is primarily preventive rather than an immediate bronchodilator, it should not be described as a rescue treatment for acute bronchospasm.
Nedocromil has also been associated with ophthalmic preparations used for allergic conjunctival conditions.
Its mast-cell stabilizing activity can help reduce allergic inflammatory responses affecting ocular tissues.
Nedocromil is generally described as a white to off-white crystalline solid/powder. Its physicochemical properties, particle characteristics and solid-state form should be controlled according to the applicable pharmaceutical/API specification.
Nedocromil should be distinguished from nedocromil sodium, which is a salt form with a different molecular composition and molecular weight.
A controlled Nedocromil API manufacturing process may involve:
Typical Nedocromil API testing may include:
Store Nedocromil API in a tightly closed container under controlled pharmaceutical storage conditions, protected from excessive moisture, heat and direct light.
Final storage conditions should be established according to validated stability data and the applicable API specification.
Nedocromil is relevant to research involving:
| Parameter | Specification |
|---|---|
| Appearance | White crystalline powder or crystals |
| Identification | IR & HPLC compliant |
| Assay (HPLC) | 98.0% – 102.0% |
| Loss on Drying | NMT 0.5% |
| Residue on Ignition | NMT 0.1% |
| Heavy Metals | NMT 20 ppm |
| Individual Impurity | NMT 0.5% |
| Total Impurities | NMT 1.0% |
| Water Content | NMT 0.5% |
| Melting Point | 298–300°C (decomposes) |